These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 29516878)

  • 1. Predictive factors for pituitary response to pulsatile GnRH therapy in patients with congenital hypogonadotropic hypogonadism.
    Mao JF; Wang X; Zheng JJ; Liu ZX; Xu HL; Huang BK; Nie M; Wu XY
    Asian J Androl; 2018; 20(4):319-323. PubMed ID: 29516878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Pulsatile Gonadotropin-Releasing Hormone Therapy in Male Patients: Comparison between Pituitary Stalk Interruption Syndrome and Congenital Hypogonadotropic Hypogonadism.
    Huang Q; Mao J; Wang X; Yu B; Ma W; Ji W; Zhu Y; Zhang R; Sun B; Zhang J; Nie M; Wu X
    Endocr Pract; 2022 May; 28(5):521-527. PubMed ID: 35218954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
    Liu L; Banks SM; Barnes KM; Sherins RJ
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulsatile gonadotropin-releasing hormone therapy is associated with earlier spermatogenesis compared to combined gonadotropin therapy in patients with congenital hypogonadotropic hypogonadism.
    Mao JF; Liu ZX; Nie M; Wang X; Xu HL; Huang BK; Zheng JJ; Min L; Kaiser UB; Wu XY
    Asian J Androl; 2017; 19(6):680-685. PubMed ID: 28051040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulsatile GnRH Therapy May Restore Hypothalamus-Pituitary-Testis Axis Function in Patients With Congenital Combined Pituitary Hormone Deficiency: A Prospective, Self-Controlled Trial.
    Zheng J; Mao J; Xu H; Wang X; Huang B; Liu Z; Cui M; Xiong S; Ma W; Min L; Kaiser UB; Nie M; Wu X
    J Clin Endocrinol Metab; 2017 Jul; 102(7):2291-2300. PubMed ID: 28368486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulsatile gonadotropin releasing hormone therapy for spermatogenesis in congenital hypogonadotropic hypogonadism patients who had poor response to combined gonadotropin therapy.
    Huang Z; Wang X; Yu B; Ma W; Zhang P; Wu X; Nie M; Mao J
    Arch Endocrinol Metab; 2024 May; 68():e230101. PubMed ID: 38739523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulsatile Gonadotropin-Releasing Hormone Therapy Is Associated With Better Spermatogenic Outcomes than Gonadotropin Therapy in Patients With Pituitary Stalk Interruption Syndrome.
    Zhang J; Zhu Y; Zhang R; Liu H; Sun B; Zhang W; Wang X; Nie M; Mao J; Wu X
    Endocr Pract; 2024 Feb; 30(2):146-154. PubMed ID: 38029930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital idiopathic hypogonadotropic hypogonadism: evidence of defects in the hypothalamus, pituitary, and testes.
    Sykiotis GP; Hoang XH; Avbelj M; Hayes FJ; Thambundit A; Dwyer A; Au M; Plummer L; Crowley WF; Pitteloud N
    J Clin Endocrinol Metab; 2010 Jun; 95(6):3019-27. PubMed ID: 20382682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypogonadotropic hypogonadism in severe beta-thalassemia: effect of chelation and pulsatile gonadotropin-releasing hormone therapy.
    Wang C; Tso SC; Todd D
    J Clin Endocrinol Metab; 1989 Mar; 68(3):511-6. PubMed ID: 2493034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-responsiveness of serum gonadotropins and testosterone to pulsatile GnRH in hemochromatosis suggesting a pituitary defect.
    Duranteau L; Chanson P; Blumberg-Tick J; Thomas G; Brailly S; Lubetzki J; Schaison G; Bouchard P
    Acta Endocrinol (Copenh); 1993 Apr; 128(4):351-4. PubMed ID: 8498154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulsatile luteinizing hormone-releasing hormone treatment of male hypogonadotropic hypogonadism.
    Aulitzky W; Frick J; Galvan G
    Fertil Steril; 1988 Sep; 50(3):480-6. PubMed ID: 3137102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulsatile gonadotropin secretion after discontinuation of long term gonadotropin-releasing hormone (GnRH) administration in a subset of GnRH-deficient men.
    Finkelstein JS; Spratt DI; O'Dea LS; Whitcomb RW; Klibanski A; Schoenfeld DA; Crowley WF
    J Clin Endocrinol Metab; 1989 Aug; 69(2):377-85. PubMed ID: 2502554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of idiopathic hypogonadotropic hypogonadism: a cohort study in Chinese patients.
    Mao JF; Xu HL; Duan J; Chen RR; Li L; Li B; Nie M; Min L; Zhang HB; Wu XY
    Asian J Androl; 2015; 17(3):497-502. PubMed ID: 25578938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of male hypogonadotropic hypogonadism and constitutional delay of puberty by pulsatile administration of gonadotropin-releasing hormone.
    Partsch CJ; Hermanussen M; Sippell WG
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1196-203. PubMed ID: 3923024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed puberty in males with beta-thalassemia major: pulsatile gonadotropin-releasing hormone administration induces changes in gonadotropin isoform profiles and an increase in sex steroids.
    Valenti S; Giusti M; McGuinness D; Guido R; Mori PG; Giordano G; Dahl KD
    Eur J Endocrinol; 1995 Jul; 133(1):48-56. PubMed ID: 7627337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in levels of testosterone, insulin sensitivity and metabolic profiles during GnRH therapy: Reciprocity between insulin sensitivity and pituitary responsiveness to GnRH in teenage and young male patients with congenital hypogonadotropic hypogonadism.
    Fan HQ; Wang YC; He W; Zhou HW; Yang T
    Clin Endocrinol (Oxf); 2022 Dec; 97(6):783-791. PubMed ID: 36181235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism.
    Pitteloud N; Hayes FJ; Dwyer A; Boepple PA; Lee H; Crowley WF
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4128-36. PubMed ID: 12213860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of pulsatile GnRH therapy on pituitary-testicular axis function in male patients with pituitary stalk interruption syndrome].
    Zheng JJ; Mao JF; Wu XY; Wang X; Liu ZX; Huang BK
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(21):1668-72. PubMed ID: 27290707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic hypogonadotropic hypogonadism in men: dependence of the hormone responses to gonadotropin-releasing hormone (GnRH) on the magnitude of the endogenous GnRH secretory defect.
    Barkan AL; Reame NE; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1118-25. PubMed ID: 3932448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.